As the importance and number of Oligonucleotide therapeutics grows, so too does the need for characterization methodologies both during drug development and production. Because structure is so intricately entwined in therapeutic efficacy for this class of drug, detailed characterization of structure is critical. Nuclear Magnetic Resonance (NMR) can deliver detailed structural information that spans the breadth of the different oligonucleotide-base therapies being developed. This webinar will detail some of the latest advancements in NMR oligonucleotide-based drug characterization.

To watch: on demand